EMEA (Europe, Middle East and Africa) Cancer Gene Therapy Market Report 2017

January 2018 | 127 pages | ID: ED3DE90531CEN
QYResearch

Abstracts

In this report, the EMEA Cancer Gene Therapy market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (Units), revenue (Million USD), market share and growth rate of Cancer Gene Therapy for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Cancer Gene Therapy market competition by top manufacturers/players, with Cancer Gene Therapy sales volume (Units), price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Adaptimmune
• GlaxoSmithKline
• Bluebird bio
• Merck
• Celgene
• Shanghai Sunway Biotech
• BioCancell
• Shenzhen SiBiono GeneTech
• SynerGene Therapeutics
• OncoGenex Pharmaceuticals
• Genelux Corporation
• Cell Genesys
• Advantagene
• GenVec
• BioCancell
• Celgene
• Epeius Biotechnologies
• Introgen Therapeutics
• Ziopharm Oncology
• Shenzhen SiBiono GeneTech
• Altor Bioscience

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Gene Induced Immunotherapy
• Oncolytic Virotherapy
• Gene Transfer

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospitals
• Diagnostics Centers
• Research Institutes

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Cancer Gene Therapy Market Report 2017

1 CANCER GENE THERAPY OVERVIEW

1.1 Product Overview and Scope of Cancer Gene Therapy
1.2 Classification of Cancer Gene Therapy
  1.2.1 EMEA Cancer Gene Therapy Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Cancer Gene Therapy Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Gene Induced Immunotherapy
  1.2.4 Oncolytic Virotherapy
  1.2.5 Gene Transfer
1.3 EMEA Cancer Gene Therapy Market by Application/End Users
  1.3.1 EMEA Cancer Gene Therapy Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospitals
  1.3.3 Diagnostics Centers
  1.3.4 Research Institutes
1.4 EMEA Cancer Gene Therapy Market by Region
  1.4.1 EMEA Cancer Gene Therapy Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Cancer Gene Therapy (2012-2022)
  1.5.1 EMEA Cancer Gene Therapy Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Cancer Gene Therapy Revenue and Growth Rate (2012-2022)

2 EMEA CANCER GENE THERAPY COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Cancer Gene Therapy Market Competition by Players/Manufacturers
  2.1.1 EMEA Cancer Gene Therapy Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Cancer Gene Therapy Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Cancer Gene Therapy Sale Price by Players (2012-2017)
2.2 EMEA Cancer Gene Therapy (Volume and Value) by Type/Product Category
  2.2.1 EMEA Cancer Gene Therapy Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Cancer Gene Therapy Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Cancer Gene Therapy Sale Price by Type (2012-2017)
2.3 EMEA Cancer Gene Therapy (Volume) by Application
2.4 EMEA Cancer Gene Therapy (Volume and Value) by Region
  2.4.1 EMEA Cancer Gene Therapy Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Cancer Gene Therapy Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Cancer Gene Therapy Sales Price by Region (2012-2017)

3 EUROPE CANCER GENE THERAPY (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Cancer Gene Therapy Sales and Value (2012-2017)
  3.1.1 Europe Cancer Gene Therapy Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Cancer Gene Therapy Revenue and Growth Rate (2012-2017)
3.2 Europe Cancer Gene Therapy Sales and Market Share by Type
3.3 Europe Cancer Gene Therapy Sales and Market Share by Application
3.4 Europe Cancer Gene Therapy Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Cancer Gene Therapy Sales Volume by Countries (2012-2017)
  3.4.2 Europe Cancer Gene Therapy Revenue by Countries (2012-2017)
  3.4.3 Germany Cancer Gene Therapy Sales and Growth Rate (2012-2017)
  3.4.4 France Cancer Gene Therapy Sales and Growth Rate (2012-2017)
  3.4.5 UK Cancer Gene Therapy Sales and Growth Rate (2012-2017)
  3.4.6 Russia Cancer Gene Therapy Sales and Growth Rate (2012-2017)
  3.4.7 Italy Cancer Gene Therapy Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Cancer Gene Therapy Sales and Growth Rate (2012-2017)

4 MIDDLE EAST CANCER GENE THERAPY (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Cancer Gene Therapy Sales and Value (2012-2017)
  4.1.1 Middle East Cancer Gene Therapy Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Cancer Gene Therapy Revenue and Growth Rate (2012-2017)
4.2 Middle East Cancer Gene Therapy Sales and Market Share by Type
4.3 Middle East Cancer Gene Therapy Sales and Market Share by Application
4.4 Middle East Cancer Gene Therapy Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Cancer Gene Therapy Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Cancer Gene Therapy Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Cancer Gene Therapy Sales and Growth Rate (2012-2017)
  4.4.4 Israel Cancer Gene Therapy Sales and Growth Rate (2012-2017)
  4.4.5 UAE Cancer Gene Therapy Sales and Growth Rate (2012-2017)
  4.4.6 Iran Cancer Gene Therapy Sales and Growth Rate (2012-2017)

5 AFRICA CANCER GENE THERAPY (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Cancer Gene Therapy Sales and Value (2012-2017)
  5.1.1 Africa Cancer Gene Therapy Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Cancer Gene Therapy Revenue and Growth Rate (2012-2017)
5.2 Africa Cancer Gene Therapy Sales and Market Share by Type
5.3 Africa Cancer Gene Therapy Sales and Market Share by Application
5.4 Africa Cancer Gene Therapy Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Cancer Gene Therapy Sales Volume by Countries (2012-2017)
  5.4.2 Africa Cancer Gene Therapy Revenue by Countries (2012-2017)
  5.4.3 South Africa Cancer Gene Therapy Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Cancer Gene Therapy Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Cancer Gene Therapy Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Cancer Gene Therapy Sales and Growth Rate (2012-2017)

6 EMEA CANCER GENE THERAPY MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Adaptimmune
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Cancer Gene Therapy Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Adaptimmune Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 GlaxoSmithKline
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Cancer Gene Therapy Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GlaxoSmithKline Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Bluebird bio
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Cancer Gene Therapy Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bluebird bio Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Merck
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Cancer Gene Therapy Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Merck Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Celgene
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Cancer Gene Therapy Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Celgene Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Shanghai Sunway Biotech
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Cancer Gene Therapy Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Shanghai Sunway Biotech Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 BioCancell
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Cancer Gene Therapy Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 BioCancell Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Shenzhen SiBiono GeneTech
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Cancer Gene Therapy Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 SynerGene Therapeutics
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Cancer Gene Therapy Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 SynerGene Therapeutics Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 OncoGenex Pharmaceuticals
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Cancer Gene Therapy Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Genelux Corporation
6.12 Cell Genesys
6.13 Advantagene
6.14 GenVec
6.15 BioCancell
6.16 Celgene
6.17 Epeius Biotechnologies
6.18 Introgen Therapeutics
6.19 Ziopharm Oncology
6.20 Shenzhen SiBiono GeneTech
6.21 Altor Bioscience

7 CANCER GENE THERAPY MANUFACTURING COST ANALYSIS

7.1 Cancer Gene Therapy Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cancer Gene Therapy

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Cancer Gene Therapy Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cancer Gene Therapy Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA CANCER GENE THERAPY MARKET FORECAST (2017-2022)

11.1 EMEA Cancer Gene Therapy Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Cancer Gene Therapy Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Cancer Gene Therapy Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Cancer Gene Therapy Price and Trend Forecast (2017-2022)
11.2 EMEA Cancer Gene Therapy Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Cancer Gene Therapy Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Cancer Gene Therapy Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Cancer Gene Therapy Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Cancer Gene Therapy Sales Forecast by Type (2017-2022)
11.7 EMEA Cancer Gene Therapy Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Cancer Gene Therapy
Figure EMEA Cancer Gene Therapy Sales Volume (Units) by Type (2012-2022)
Figure EMEA Cancer Gene Therapy Sales Volume Market Share by Type (Product Category) in 2016
Figure Gene Induced Immunotherapy Product Picture
Figure Oncolytic Virotherapy Product Picture
Figure Gene Transfer Product Picture
Figure EMEA Cancer Gene Therapy Sales Volume (Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Cancer Gene Therapy by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Diagnostics Centers Examples
Table Key Downstream Customer in Diagnostics Centers
Figure Research Institutes Examples
Table Key Downstream Customer in Research Institutes
Figure EMEA Cancer Gene Therapy Market Size (Million USD) by Region (2012-2022)
Figure Europe Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Cancer Gene Therapy Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Cancer Gene Therapy Revenue (Million USD) Status and Forecast by Countries
Figure Africa Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Cancer Gene Therapy Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Cancer Gene Therapy Sales Volume and Growth Rate (2012-2022)
Figure EMEA Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Cancer Gene Therapy Market Major Players Product Sales Volume (Units) (2012-2017)
Table EMEA Cancer Gene Therapy Sales Volume (Units) of Major Players (2012-2017)
Table EMEA Cancer Gene Therapy Sales Share by Players (2012-2017)
Figure 2016 Cancer Gene Therapy Sales Share by Players
Figure 2017 Cancer Gene Therapy Sales Share by Players
Figure EMEA Cancer Gene Therapy Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Cancer Gene Therapy Revenue (Million USD) by Players (2012-2017)
Table EMEA Cancer Gene Therapy Revenue Share by Players (2012-2017)
Table 2016 EMEA Cancer Gene Therapy Revenue Share by Players
Table 2017 EMEA Cancer Gene Therapy Revenue Share by Players
Table EMEA Cancer Gene Therapy Sale Price (K USD/Unit) by Players (2012-2017)
Table EMEA Cancer Gene Therapy Sales (Units) and Market Share by Type (2012-2017)
Table EMEA Cancer Gene Therapy Sales Share by Type (2012-2017)
Figure Sales Market Share of Cancer Gene Therapy by Type (2012-2017)
Figure EMEA Cancer Gene Therapy Sales Market Share by Type (2012-2017)
Table EMEA Cancer Gene Therapy Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Cancer Gene Therapy Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cancer Gene Therapy by Type in 2016
Table EMEA Cancer Gene Therapy Sale Price (K USD/Unit) by Type (2012-2017)
Table EMEA Cancer Gene Therapy Sales (Units) and Market Share by Application (2012-2017)
Table EMEA Cancer Gene Therapy Sales Share by Application (2012-2017)
Figure Sales Market Share of Cancer Gene Therapy by Application (2012-2017)
Figure EMEA Cancer Gene Therapy Sales Market Share by Application in 2016
Table EMEA Cancer Gene Therapy Sales (Units) and Market Share by Region (2012-2017)
Table EMEA Cancer Gene Therapy Sales Share by Region (2012-2017)
Figure Sales Market Share of Cancer Gene Therapy by Region (2012-2017)
Figure EMEA Cancer Gene Therapy Sales Market Share in 2016
Table EMEA Cancer Gene Therapy Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Cancer Gene Therapy Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Cancer Gene Therapy by Region (2012-2017)
Figure EMEA Cancer Gene Therapy Revenue Market Share Regions in 2016
Table EMEA Cancer Gene Therapy Sales Price (K USD/Unit) by Region (2012-2017)
Figure Europe Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure Europe Cancer Gene Therapy Revenue and Growth Rate (2012-2017)
Table Europe Cancer Gene Therapy Sales (Units) by Type (2012-2017)
Table Europe Cancer Gene Therapy Market Share by Type (2012-2017)
Figure Europe Cancer Gene Therapy Market Share by Type in 2016
Table Europe Cancer Gene Therapy Sales (Units) by Application (2012-2017)
Table Europe Cancer Gene Therapy Market Share by Application (2012-2017)
Figure Europe Cancer Gene Therapy Market Share by Application in 2016
Table Europe Cancer Gene Therapy Sales (Units) by Countries (2012-2017)
Table Europe Cancer Gene Therapy Sales Market Share by Countries (2012-2017)
Figure Europe Cancer Gene Therapy Sales Market Share by Countries (2012-2017)
Figure Europe Cancer Gene Therapy Sales Market Share by Countries in 2016
Table Europe Cancer Gene Therapy Revenue (Million USD) by Countries (2012-2017)
Table Europe Cancer Gene Therapy Revenue Market Share by Countries (2012-2017)
Figure Europe Cancer Gene Therapy Revenue Market Share by Countries (2012-2017)
Figure Europe Cancer Gene Therapy Revenue Market Share by Countries in 2016
Figure Germany Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure France Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure UK Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure Russia Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure Italy Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure Benelux Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure Middle East Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure Middle East Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Cancer Gene Therapy Sales (Units) by Type (2012-2017)
Table Middle East Cancer Gene Therapy Market Share by Type (2012-2017)
Figure Middle East Cancer Gene Therapy Market Share by Type (2012-2017)
Table Middle East Cancer Gene Therapy Sales (Units) by Applications (2012-2017)
Table Middle East Cancer Gene Therapy Market Share by Applications (2012-2017)
Figure Middle East Cancer Gene Therapy Sales Market Share by Application in 2016
Table Middle East Cancer Gene Therapy Sales Volume (Units) by Countries (2012-2017)
Table Middle East Cancer Gene Therapy Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Cancer Gene Therapy Sales Volume Market Share by Countries in 2016
Table Middle East Cancer Gene Therapy Revenue (Million USD) by Countries (2012-2017)
Table Middle East Cancer Gene Therapy Revenue Market Share by Countries (2012-2017)
Figure Middle East Cancer Gene Therapy Revenue Market Share by Countries (2012-2017)
Figure Middle East Cancer Gene Therapy Revenue Market Share by Countries in 2016
Figure Saudi Arabia Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure Israel Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure UAE Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure Iran Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure Africa Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure Africa Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Cancer Gene Therapy Sales (Units) by Type (2012-2017)
Table Africa Cancer Gene Therapy Sales Market Share by Type (2012-2017)
Figure Africa Cancer Gene Therapy Sales Market Share by Type (2012-2017)
Figure Africa Cancer Gene Therapy Sales Market Share by Type in 2016
Table Africa Cancer Gene Therapy Sales (Units) by Application (2012-2017)
Table Africa Cancer Gene Therapy Sales Market Share by Application (2012-2017)
Figure Africa Cancer Gene Therapy Sales Market Share by Application (2012-2017)
Table Africa Cancer Gene Therapy Sales Volume (Units) by Countries (2012-2017)
Table Africa Cancer Gene Therapy Sales Market Share by Countries (2012-2017)
Figure Africa Cancer Gene Therapy Sales Market Share by Countries (2012-2017)
Figure Africa Cancer Gene Therapy Sales Market Share by Countries in 2016
Table Africa Cancer Gene Therapy Revenue (Million USD) by Countries (2012-2017)
Table Africa Cancer Gene Therapy Revenue Market Share by Countries (2012-2017)
Figure Africa Cancer Gene Therapy Revenue Market Share by Countries (2012-2017)
Figure Africa Cancer Gene Therapy Revenue Market Share by Countries in 2016
Figure South Africa Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure Nigeria Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure Egypt Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure Algeria Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Table Adaptimmune Cancer Gene Therapy Basic Information List
Table Adaptimmune Cancer Gene Therapy Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Adaptimmune Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure Adaptimmune Cancer Gene Therapy Sales Market Share in EMEA (2012-2017)
Figure Adaptimmune Cancer Gene Therapy Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline Cancer Gene Therapy Basic Information List
Table GlaxoSmithKline Cancer Gene Therapy Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Cancer Gene Therapy Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline Cancer Gene Therapy Revenue Market Share in EMEA (2012-2017)
Table Bluebird bio Cancer Gene Therapy Basic Information List
Table Bluebird bio Cancer Gene Therapy Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Bluebird bio Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure Bluebird bio Cancer Gene Therapy Sales Market Share in EMEA (2012-2017)
Figure Bluebird bio Cancer Gene Therapy Revenue Market Share in EMEA (2012-2017)
Table Merck Cancer Gene Therapy Basic Information List
Table Merck Cancer Gene Therapy Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Merck Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure Merck Cancer Gene Therapy Sales Market Share in EMEA (2012-2017)
Figure Merck Cancer Gene Therapy Revenue Market Share in EMEA (2012-2017)
Table Celgene Cancer Gene Therapy Basic Information List
Table Celgene Cancer Gene Therapy Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Celgene Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure Celgene Cancer Gene Therapy Sales Market Share in EMEA (2012-2017)
Figure Celgene Cancer Gene Therapy Revenue Market Share in EMEA (2012-2017)
Table Shanghai Sunway Biotech Cancer Gene Therapy Basic Information List
Table Shanghai Sunway Biotech Cancer Gene Therapy Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Shanghai Sunway Biotech Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure Shanghai Sunway Biotech Cancer Gene Therapy Sales Market Share in EMEA (2012-2017)
Figure Shanghai Sunway Biotech Cancer Gene Therapy Revenue Market Share in EMEA (2012-2017)
Table BioCancell Cancer Gene Therapy Basic Information List
Table BioCancell Cancer Gene Therapy Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure BioCancell Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure BioCancell Cancer Gene Therapy Sales Market Share in EMEA (2012-2017)
Figure BioCancell Cancer Gene Therapy Revenue Market Share in EMEA (2012-2017)
Table Shenzhen SiBiono GeneTech Cancer Gene Therapy Basic Information List
Table Shenzhen SiBiono GeneTech Cancer Gene Therapy Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Shenzhen SiBiono GeneTech Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure Shenzhen SiBiono GeneTech Cancer Gene Therapy Sales Market Share in EMEA (2012-2017)
Figure Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue Market Share in EMEA (2012-2017)
Table SynerGene Therapeutics Cancer Gene Therapy Basic Information List
Table SynerGene Therapeutics Cancer Gene Therapy Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure SynerGene Therapeutics Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure SynerGene Therapeutics Cancer Gene Therapy Sales Market Share in EMEA (2012-2017)
Figure SynerGene Therapeutics Cancer Gene Therapy Revenue Market Share in EMEA (2012-2017)
Table OncoGenex Pharmaceuticals Cancer Gene Therapy Basic Information List
Table OncoGenex Pharmaceuticals Cancer Gene Therapy Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure OncoGenex Pharmaceuticals Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure OncoGenex Pharmaceuticals Cancer Gene Therapy Sales Market Share in EMEA (2012-2017)
Figure OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue Market Share in EMEA (2012-2017)
Table Genelux Corporation Cancer Gene Therapy Basic Information List
Table Cell Genesys Cancer Gene Therapy Basic Information List
Table Advantagene Cancer Gene Therapy Basic Information List
Table GenVec Cancer Gene Therapy Basic Information List
Table BioCancell Cancer Gene Therapy Basic Information List
Table Celgene Cancer Gene Therapy Basic Information List
Table Epeius Biotechnologies Cancer Gene Therapy Basic Information List
Table Introgen Therapeutics Cancer Gene Therapy Basic Information List
Table Ziopharm Oncology Cancer Gene Therapy Basic Information List
Table Shenzhen SiBiono GeneTech Cancer Gene Therapy Basic Information List
Table Altor Bioscience Cancer Gene Therapy Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Gene Therapy
Figure Manufacturing Process Analysis of Cancer Gene Therapy
Figure Cancer Gene Therapy Industrial Chain Analysis
Table Raw Materials Sources of Cancer Gene Therapy Major Manufacturers in 2016
Table Major Buyers of Cancer Gene Therapy
Table Distributors/Traders List
Figure EMEA Cancer Gene Therapy Sales (Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Cancer Gene Therapy Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Cancer Gene Therapy Price (K USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Cancer Gene Therapy Sales (Units) Forecast by Region (2017-2022)
Figure EMEA Cancer Gene Therapy Sales Market Share Forecast by Region (2017-2022)
Table EMEA Cancer Gene Therapy Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Cancer Gene Therapy Revenue Market Share Forecast by Region (2017-2022)
Table Europe Cancer Gene Therapy Sales (Units) Forecast by Countries (2017-2022)
Figure Europe Cancer Gene Therapy Sales Market Share Forecast by Countries (2017-2022)
Table Europe Cancer Gene Therapy Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Cancer Gene Therapy Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Cancer Gene Therapy Sales (Units) Forecast by Countries (2017-2022)
Figure Middle East Cancer Gene Therapy Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Cancer Gene Therapy Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Cancer Gene Therapy Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Cancer Gene Therapy Sales (Units) Forecast by Countries (2017-2022)
Figure Africa Cancer Gene Therapy Sales Market Share Forecast by Countries (2017-2022)
Table Africa Cancer Gene Therapy Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Cancer Gene Therapy Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Cancer Gene Therapy Sales (Units) Forecast by Type (2017-2022)
Figure EMEA Cancer Gene Therapy Sales Market Share Forecast by Type (2017-2022)
Table EMEA Cancer Gene Therapy Sales (Units) Forecast by Application (2017-2022)
Figure EMEA Cancer Gene Therapy Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources